missing translation for 'onlineSavingsMsg'
Learn More
Learn More
SLC25A13 Rabbit anti-Human, Mouse, Rat, Polyclonal, Proteintech
Tous les produits Proteintech ProduitsDescription
Citrin, also known as SLC25A13 (Solute carrier family 25 member 13), ARALAR2 or CTLN2, is a 675 amino acid multi-pass membrane protein that localizes to the inner membrane of the mitochondrion. Expressed in liver, pancreas, kidney, brain, heart and placenta, citrin functions as a calcium-dependent glutamate and aspartate carrier that is thought to play a role in the urea cycle. Citrin, a member of the mitochondrial carrier family, contains three Solcar repeats and four EF-hand domains through which it binds calcium. Defects in the gene encoding citrin are the cause of citrullinemia type 2 (CTLN2) and neonatal intrahepatic cholestasis due to citrin deficiency (NICCD). CTLN2 is an autosomal recessive disease that results from errors in the urea cycle and is characterized by neuropsychiatric symptoms such as loss of memory, seizures and coma. NICCD, a non-lethal disorder, occurs during infancy and is characterized by low birth weight, reduced bile flow, growth retardation and hepatic fibrosis.
Spécification
Spécification
| Antigène | SLC25A13 |
| Applications | Immunohistochemistry (Paraffin), Immunoprecipitation, Western Blot |
| Classification | Polyclonal |
| Concentration | 0.3 mg/mL |
| Conjugué | Unconjugated |
| Formule | PBS with 50% glycerol and 0.1% sodium azide; pH 7.3 |
| Expression | SLC25A13 |
| Numéro d’ordre du gène | Q9QXX4, Q9UJS0 |
| Alias de gène | ARALAR2, CITRIN, CTLN2, SLC25A13 |
| Symboles de gène(s) | Slc25a13 |
| Afficher plus |
Nom du produit
En cliquant sur Soumettre, vous reconnaissez que vous pouvez être contacté par Fisher Scientific au sujet des informations que vous avez fournies dans ce formulaire. Nous ne partagerons pas vos informations à d'autres fins. Toutes les informations de contact fournies seront également conservées conformément à notre politique de confidentialité. Politique de confidentialité.
Vous avez repéré une opportunité d'amélioration ?